Concepedia

Roelf Valkema

RV

Statistics

Publications

104

Citations

7.4K

H-Index

41

Active since

1989

Affiliations

Erasmus University Rotterdam(Current)

Erasmus MC

Rotterdam University of Applied Sciences

Leiden University

Leiden University Medical Center

Roelf Valkema is an author at Erasmus University Rotterdam specializing in medicine, nuclear medicine, and oncology.

Publications per year

1989–2025

104

Publications

104

Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

Roelf Valkema, Marion de Jong, Willem H. Bakker et al. · Seminars in Nuclear Medicine · 2002 · 433 citations

, , +14

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Dik J. Kwekkeboom, Jan Mueller‐Brand, Giovanni Paganelli et al. · PubMed · 2005 · 375 citations · Full text

, , +17

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Roelf Valkema, Stanislas Pauwels, Larry K. Kvols et al. · PubMed · 2005 · 334 citations · Full text

, , +16

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema et al. · The Lancet Oncology · 2018 · 332 citations

, , +17

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

Edgar J. Rolleman, Roelf Valkema, Marion de Jong et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 316 citations

, , +14

1–5 of 104